NLS Pharmaceutics Ltd. at its Annual General Meeting held on June 30, 2023 approved the election of Audrey Greenberg and Dr. Anthony Walsh to the Board of Directors. Audrey Greenberg, Co-Founder and Chief Business Officer, Center for Breakthrough Medicines, and Anthony Walsh, PhD, Chief Business Officer of Ability Biologics, were both elected to the NLS Pharmaceutics Board of Directors, broadening the board membership to include U.S. representation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1393 USD | -1.55% | +0.94% | -76.39% |
08/04 | Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors | CI |
03/04 | NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-76.39% | 6.57M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NLSP Stock
- News NLS Pharmaceutics Ltd.
- NLS Pharmaceutics Ltd. Approves Board Appointments